Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | CNR1 | P21554 | 2/20 | 0.54 |
| ▸ | NAAA | Q02083 | 2/20 | 0.54 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13822112 | 0.99 | KDM4E (0.58) | KDM4ECNR1NAAAEPHX1KMT2A | |
| SCHEMBL27918571 | 0.94 | ALDH1A1 (0.52) | KDM4ECNR1KMT2AL3MBTL1NPC1 | |
| SCHEMBL14904964 | 0.89 | KMT2A (0.52) | KMT2ANPC1RAB9AKDM4CPOLB | |
| SCHEMBL6072144 | 0.88 | L3MBTL1 (0.55) | KMT2AL3MBTL1NPC1RAB9AALOX15 | |
| SCHEMBL14904965 | 0.86 | KMT2A (0.50) | CNR1KMT2AKDM4CPOLBMEN1 | |
| SCHEMBL3546147 | 0.83 | ALOX15 (0.62) | KDM4EKMT2AL3MBTL1NPC1RAB9A | |
| SCHEMBL14894349 | 0.83 | KMT2A (0.55) | KMT2ANPC1RAB9AKDM4CPOLB | |
| SCHEMBL14905101 | 0.82 | TDP1 (0.51) | KMT2AL3MBTL1NPC1RAB9AALDH1A1 | |
| SCHEMBL620738 | 0.82 | L3MBTL1 (0.58) | KDM4EKMT2AL3MBTL1NPC1RAB9A | |
| SCHEMBL620675 | 0.82 | KDM4C (0.54) | KMT2AL3MBTL1NPC1RAB9AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060241149-A1 | Chemical compounds | ADAMS JERRY L | 2006-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060241149-A1 | Chemical compounds | CHKB, MAP3K20, MAP3K6 | KDM4E 2777/4885CNR1 1548/4885NAAA 2844/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.